secwatch.observer — SEC 8-K summary
======================================

Issuer:     C4 Therapeutics, Inc. (CCCC)
CIK:        0001662579
Form:       8-K
Filed at:   2023-09-05T23:59:59+00:00
Accession:  0001628280-23-031375
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

C4 Therapeutics CFO Lauren White to step down; Kendra Adams named successor
---------------------------------------------------------------------------

- Lauren White resigns as CFO, Treasurer, and principal financial/accounting officer effective September 15, 2023; no disagreement cited.
- Kendra Adams appointed CFO effective September 18, 2023; previously SVP, Communications and IR at C4T since Nov 2020.
- Mark Mossler appointed Chief Accounting Officer and principal accounting officer effective Sept 18, 2023; previously VP, Corporate Controller since June 2023.
- Adams receives $450K base salary, 40% bonus target, option for 111,000 shares, and 25,000 RSUs.
- Mossler receives $315K base salary, 30% bonus target.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1662579/000162828023031375/0001628280-23-031375-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1662579/000162828023031375/cccc-20230905.htm
  HTML page:      https://secwatch.observer/filing/0001628280-23-031375

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer